Evidence map›Paper›PMID 38342477›Full record

Trial reportAmerican journal of preventive medicine2024

Smoking Cessation by Cancer Treatment Status Among Cervical Cancer Survivors.

Cherell Cottrell-Daniels, Charles E Hoogland, Bethany Shorey Fennell, Vani N Simmons, Damon J Vidrine, Jennifer I Vidrine

Open access · greenAbstract readRandomized Controlled Trial
PubMed Full text at PMC Publisher
In one paragraph

Trial report in American journal of preventive medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Cherell Cottrell-DanielsDepartment of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, Florida.
Charles E HooglandDepartment of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, Florida.
Bethany Shorey FennellDepartment of Family and Community Medicine and Markey Cancer Center, University of Kentucky, Lexington, Kentucky.
Vani N SimmonsDepartment of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, Florida; Department of Oncologic Sciences, Morsani College of Medicine, University of South Florida, Tampa, Florida; Department of Psychology, University of South Florida, Tampa, Florida.
Damon J VidrineDepartment of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, Florida; Department of Oncologic Sciences, Morsani College of Medicine, University of South Florida, Tampa, Florida.
Jennifer I VidrineDepartment of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, Florida; Department of Oncologic Sciences, Morsani College of Medicine, University of South Florida, Tampa, Florida; Department of Psychology, University of South Florida, Tampa, Florida. Electronic address: Jennifer.Vidrine@Moffitt.org.
University of South Florida · USMoffitt Cancer Center · USMarkey Cancer Center · US

Funding

TRANSLATIONAL RESEARCHP30CA076292 · NCI · UNIVERSITY OF SOUTH FLORIDA · PI John L. Cleveland · 1998 to 2026
$93.5M
Behavioral Oncology Education & Career DevelopmentT32CA090314 · NCI · H. LEE MOFFITT CANCER CTR & RES INST · PI Vani N Simmons, SUSAN T VADAPARAMPIL · 2019 to 2026
$2.9M
Smoking Cessation for Cervical Cancer Survivors in a Safety Net Healthcare SystemR01CA172786 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI VIDRINE, JENNIFER IRVIN · 2014 to 2019
$2.4M
NCI NIH HHS P30 CA076292NCI NIH HHS R01 CA172786NCI NIH HHS T32 CA090314
6 · The paper itself

Abstract

introductionContinued smoking following a cancer diagnosis is associated with poorer cancer treatment outcomes and survival times. Little is known about how cancer treatment status at the time of tobacco treatment enrollment impacts long-term smoking cessation outcomes. Using data from a smoking cessation RCT, this study compared long-term cessation outcomes of women undergoing active treatment for cervical cancer at trial enrollment (n=40) to outcomes of women with a history of cervical cancer or cervical intraepithelial neoplasia (CIN) who were not undergoing active cancer treatment at enrollment (n=154).

methodsParticipants (n=194) were randomized to Standard Treatment (ST) or ST plus a 6-session Motivation And Problem Solving (MAPS) telephone counseling protocol (data collected: 2017-2021; analyzed: 2023). Sociodemographic differences between participants undergoing (versus not undergoing) active cancer treatment at enrollment were examined. Significant covariates were included in a logistic regression analysis comparing the 2 groups' smoking cessation outcomes at 12 months, the end of the tobacco treatment period.

resultsParticipants in active cancer treatment at enrollment were significantly younger and less educated than those not in active cancer treatment. Race/ethnicity, relationship status, household income, nicotine dependence, and tobacco treatment condition did not vary by cancer treatment status. After adjusting for tobacco treatment condition, age, and education, being in active cancer treatment at the time of enrollment was associated with lower odds of abstinence at 12 months (5% vs 20%, aOR=0.22, 95% CI [0.05-0.998]).

conclusionsFurther research is necessary to identify and overcome barriers to abstinence among cancer survivors undergoing active treatment.

Indexed as

Cancer SurvivorsSmoking CessationUterine Cervical NeoplasmsAdultCounselingFemaleHumansMiddle AgedMotivation

Identifiers

PMID38342477
PMCPMC11231988
OpenAlexW4391722930

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.